|
|
|
|
| LEADER |
01363nam a2200253 a 4500 |
| 001 |
1736588 |
| 005 |
20171111234447.0 |
| 008 |
|
| 020 |
|
|
|z 9780309158497
|
| 040 |
|
|
|a CaPaEBR
|z 0309158494
|
| 050 |
1 |
4 |
|a RA399.A3
|b I57 2010eb
|
| 110 |
2 |
|
|a Institute of Medicine (U.S.).
|b Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process.
|
| 240 |
1 |
0 |
|a FDA 510(k) clearance process
|
| 245 |
1 |
0 |
|a Public health effectiveness of the FDA 510(k) clearance process
|b balancing patient safety and innovation : workshop report /
|c Theresa Wizemann, editor ; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.
|
| 246 |
3 |
0 |
|a FDA 510(k) clearance process
|
| 260 |
|
|
|a Washington, D.C. :
|b National Academies Press,
|c 2010.
|
| 300 |
|
|
|a xii, 128 p. :
|b col. ill.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 650 |
|
0 |
|a Public health
|x Standards
|z United States
|
| 650 |
|
0 |
|a Public health
|z United States
|
| 700 |
1 |
|
|a Wizemann, Theresa.
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Board on Population Health and Public Health Practice.
|
| 856 |
4 |
0 |
|a ebrary, Inc.
|u http://site.ebrary.com/lib/ucy/Doc?id=10425162
|
| 952 |
|
|
|a CY-NiOUC
|b 5a0450586c5ad14ac1ec2644
|c 998a
|d 945l
|e -
|t 1
|x m
|z Books
|
